Cargando…

Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes

Detalles Bibliográficos
Autores principales:	Nguyen, Thuy Thi, Gapihan, Guillaume, Tetu, Pauline, Pamoukdjian, Frédéric, El Bouchtaoui, Morad, Lebœuf, Christophe, Feugeas, Jean‐Paul, Paris, Justine, Baroudjian, Barouyr, Delyon, Julie, Mourah, Samia, Lebbé, Céleste, Janin, Anne, Bousquet, Guilhem, Battistella, Maxime
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711084/ https://www.ncbi.nlm.nih.gov/pubmed/33377645 http://dx.doi.org/10.1002/ctm2.198

Ejemplares similares

EGFR is involved in dermatofibrosarcoma protuberans progression to high grade sarcoma
por: Osio, Amélie, et al.
Publicado: (2018)

Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma: A Retrospective Study
por: HERMS, Florian, et al.
Publicado: (2022)

Yield of FDG PET/CT for Defining the Extent of Disease in Patients with Kaposi Sarcoma
por: Pesqué, Louise, et al.
Publicado: (2022)

Baseline Genomic Features in BRAFV600-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care
por: Louveau, Baptiste, et al.
Publicado: (2019)

Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma
por: Reger de Moura, Coralie, et al.
Publicado: (2019)

Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma
por: Bousquet, Guilhem, et al.
Publicado: (2015)

FGF2 Induces Resistance to Nilotinib through MAPK Pathway Activation in KIT Mutated Melanoma
por: Tétu, Pauline, et al.
Publicado: (2020)

Metastatic clear-cell renal cell carcinoma: a frequent NOTCH1 mutation predictive of response to anti-NOTCH1 CB-103 treatment
por: Bui, Thi Oanh, et al.
Publicado: (2023)

High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target
por: Bousquet, Guilhem, et al.
Publicado: (2019)

Systemic Treatment Initiation in Classical and Endemic Kaposi’s Sarcoma: Risk Factors and Global Multi-State Modelling in a Monocentric Cohort Study
por: Benajiba, Lina, et al.
Publicado: (2021)

Targeting Cancer Stem Cells to Overcome Chemoresistance
por: Nunes, Toni, et al.
Publicado: (2018)

Nivolumab-induced alopecia areata: A reversible factor of good prognosis?
por: Lakhmiri, Myriam, et al.
Publicado: (2018)

Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodes
por: Furet, Elise, et al.
Publicado: (2017)

Impact of New Systemic Treatment and Radiotherapy in Melanoma Patients with Leptomeningeal Metastases
por: Tétu, Pauline, et al.
Publicado: (2020)

Correction: Validation of a preclinical model for assessment of drug efficacy in melanoma
por: Julie, Delyon, et al.
Publicado: (2016)

Validation of a preclinical model for assessment of drug efficacy in melanoma
por: Delyon, Julie, et al.
Publicado: (2016)

When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report
por: Gauci, Marie-Léa, et al.
Publicado: (2021)

Atypical BRAF and NRAS Mutations in Mucosal Melanoma
por: Dumaz, Nicolas, et al.
Publicado: (2019)

18FDG PET Assessment of Therapeutic Response in Patients with Advanced or Metastatic Melanoma Treated with First-Line Immune Checkpoint Inhibitors
por: Rivas, Alexia, et al.
Publicado: (2022)

Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer
por: Bousquet, Guilhem, et al.
Publicado: (2017)

Long-Term Outcome of Neoadjuvant Tyrosine Kinase Inhibitors Followed by Complete Surgery in Locally Advanced Dermatofibrosarcoma Protuberans
por: Beaziz, Jessica, et al.
Publicado: (2021)

A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors
por: Louveau, Baptiste, et al.
Publicado: (2019)

Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients
por: Verneuil, Laurence, et al.
Publicado: (2015)

Reintroduction of immune-checkpoint inhibitors after immune-related meningitis: a case series of melanoma patients
por: Cuzzubbo, Stefania, et al.
Publicado: (2020)

Expression of angiopoietin-like 4 fibrinogen-like domain (cANGPTL4) increases risk of brain metastases in women with breast cancer
por: Dao, Tu, et al.
Publicado: (2020)

Genomics of Breast Cancer Brain Metastases: A Meta-Analysis and Therapeutic Implications
por: Nguyen, Thuy Thi, et al.
Publicado: (2023)

Discoidin Domain Receptors in Melanoma: Potential Therapeutic Targets to Overcome MAPK Inhibitor Resistance
por: Reger de Moura, Coralie, et al.
Publicado: (2020)

CD147 Promotes Tumor Lymphangiogenesis in Melanoma via PROX-1
por: Reger de Moura, Coralie, et al.
Publicado: (2021)

A Reliable Method for the Selection of Exploitable Melanoma Archival Paraffin Embedded Tissues for Transcript Biomarker Profiling
por: Lebbe, Celeste, et al.
Publicado: (2012)

Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting
por: Romero, Martha, et al.
Publicado: (2016)

Genomics applied to the treatment of breast cancer
por: Hamdan, Diaddin, et al.
Publicado: (2019)

TERT Expression Induces Resistance to BRAF and MEK Inhibitors in BRAF-Mutated Melanoma In Vitro
por: Delyon, Julie, et al.
Publicado: (2023)

Cell Death Induced on Cell Cultures and Nude Mouse Skin by Non-Thermal, Nanosecond-Pulsed Generated Plasma
por: Duval, Arnaud, et al.
Publicado: (2013)

Endemic Kaposi’s Sarcoma
por: Zeinaty, Perla El, et al.
Publicado: (2023)

Re‐exploring immune‐related side effects of docetaxel in an observational study: Blood hypereosinophilia
por: Hamdan, Diaddin, et al.
Publicado: (2019)

A massive open online course to teach undergraduate medical students in oncology: keys of success
por: Hamdan, Diaddin, et al.
Publicado: (2022)

EMMPRIN Promotes Melanoma Cells Malignant Properties through a HIF-2alpha Mediated Up-Regulation of VEGF-Receptor-2
por: Bougatef, Faten, et al.
Publicado: (2010)

HER2 Amplification Level Predicts Pathological Complete Response in the Neoadjuvant Setting of HER2-Overexpressing Breast Cancer: A Meta-Analysis and Systematic Review
por: Gonullu, Burak, et al.
Publicado: (2023)

How to Make Anticancer Drugs Cross the Blood–Brain Barrier to Treat Brain Metastases
por: Angeli, Eurydice, et al.
Publicado: (2019)

RICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted Therapy
por: Jebali, Ahlem, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ugger48jm7morl3orq05rrjp9m